Mazabraud Yann's most recent trade in Rhythm Pharmaceuticals Inc. was a trade of 46,625 Common Stock done at an average price of $6.8 . Disclosure was reported to the exchange on Aug. 12, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.80 per share. | 12 Aug 2026 | 46,625 | 112,655 (0%) | 0% | 6.8 | 317,050 | Common Stock |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2026 | 46,625 | 35,875 | - | - | Stock Options (Right to Buy) | |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Sale of securities on an exchange or to another person at price $ 116.49 per share. | 12 Aug 2026 | 18,208 | 72,974 (0%) | 0% | 116.5 | 2,121,125 | Common Stock |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Sale of securities on an exchange or to another person at price $ 117.47 per share. | 12 Aug 2026 | 17,319 | 55,655 (0%) | 0% | 117.5 | 2,034,439 | Common Stock |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Sale of securities on an exchange or to another person at price $ 115.43 per share. | 12 Aug 2026 | 14,568 | 91,182 (0%) | 0% | 115.4 | 1,681,541 | Common Stock |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Sale of securities on an exchange or to another person at price $ 114.70 per share. | 12 Aug 2026 | 3,605 | 105,750 (0%) | 0% | 114.7 | 413,477 | Common Stock |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Sale of securities on an exchange or to another person at price $ 111.80 per share. | 12 Aug 2026 | 2,300 | 110,355 (0%) | 0% | 111.8 | 257,138 | Common Stock |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Sale of securities on an exchange or to another person at price $ 112.86 per share. | 12 Aug 2026 | 1,000 | 109,355 (0%) | 0% | 112.9 | 112,856 | Common Stock |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2026 | 12,875 | 66,030 (0%) | 0% | - | Common Stock | |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2026 | 10,375 | 10,375 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2026 | 2,500 | 5,000 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 35,000 | 35,000 | - | - | Stock Options (Right to Buy) | |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2026 | 10,000 | 53,155 (0%) | 0% | - | Common Stock | |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2026 | 10,000 | 30,000 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2026 | 23,350 | 23,350 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2026 | 5,500 | 11,000 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2026 | 5,500 | 43,155 (0%) | 0% | - | Common Stock | |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Sale of securities on an exchange or to another person at price $ 65.08 per share. | 29 Apr 2025 | 6,745 | 37,655 (0%) | 0% | 65.1 | 438,946 | Common Stock |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Apr 2025 | 11,405 | 44,400 (0%) | 0% | - | Common Stock | |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Apr 2025 | 10,375 | 20,750 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Apr 2025 | 10,375 | 32,995 (0%) | 0% | - | Common Stock | |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Apr 2025 | 8,905 | 0 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Apr 2025 | 2,500 | 7,500 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Sale of securities on an exchange or to another person at price $ 61.54 per share. | 08 Apr 2025 | 9,312 | 22,620 (0%) | 0% | 61.5 | 573,062 | Common Stock |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Sale of securities on an exchange or to another person at price $ 60.37 per share. | 08 Apr 2025 | 8,438 | 31,932 (0%) | 0% | 60.4 | 509,435 | Common Stock |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2025 | 75,000 | 25,000 | - | - | Stock Options (Right to Buy) | |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.28 per share. | 14 Mar 2025 | 75,000 | 115,370 (0%) | 0% | 22.3 | 1,671,000 | Common Stock |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Sale of securities on an exchange or to another person at price $ 51.72 per share. | 14 Mar 2025 | 55,803 | 40,370 (0%) | 0% | 51.7 | 2,886,226 | Common Stock |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Sale of securities on an exchange or to another person at price $ 50.79 per share. | 14 Mar 2025 | 19,197 | 96,173 (0%) | 0% | 50.8 | 975,046 | Common Stock |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 60,000 | 60,000 | - | - | Stock Options (Right to Buy) | |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 40,000 | 40,000 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2025 | 5,500 | 40,370 (0%) | 0% | - | Common Stock | |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2025 | 5,500 | 16,500 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Apr 2024 | 10,375 | 31,125 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Apr 2024 | 10,375 | 34,870 (0%) | 0% | - | Common Stock | |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2024 | 10,000 | 10,000 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2024 | 8,905 | 8,905 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Apr 2024 | 6,874 | 0 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Apr 2024 | 2,031 | 0 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Sale of securities on an exchange or to another person at price $ 39.22 per share. | 19 Mar 2024 | 16,000 | 24,495 (0%) | 0% | 39.2 | 627,520 | Common Stock |
| Rhythm Pharma Inc | Mazabraud Yann | EVP, Head of International | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 67,000 | 67,000 | - | - | Stock Option (Right to Buy) | |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 33,750 | 40,495 (0%) | 0% | 0 | Common Stock | |
| Rhythm Pharma Inc | Mazabraud Yann | EVP, Head of International | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2024 | 22,000 | 22,000 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | Mazabraud Yann | EVP, Head of International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 3,438 | 7,265 (0%) | 0% | - | Common Stock | |
| Rhythm Pharma Inc | Mazabraud Yann | EVP, Head of International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 3,438 | 6,874 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 2,031 | 2,031 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Feb 2024 | 2,031 | 9,296 (0%) | 0% | - | Common Stock | |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Sale of securities on an exchange or to another person at price $ 51.38 per share. | 09 Feb 2024 | 1,594 | 7,702 (0%) | 0% | 51.4 | 81,900 | Common Stock |
| Rhythm Pharma Inc | Mazabraud Yann | EVP, Head of International | Sale of securities on an exchange or to another person at price $ 49.84 per share. | 09 Feb 2024 | 957 | 6,745 (0%) | 0% | 49.8 | 47,697 | Common Stock |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Apr 2023 | 41,500 | 0 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Apr 2023 | 41,500 | 41,500 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Sale of securities on an exchange or to another person at price $ 27.03 per share. | 14 Feb 2023 | 1,177 | 3,827 (0%) | 0% | 27.0 | 31,814 | Common Stock |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 2,031 | 5,004 (0%) | 0% | - | Common Stock | |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 2,031 | 4,062 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Sale of securities on an exchange or to another person at price $ 27.51 per share. | 09 Feb 2023 | 1,563 | 2,973 (0%) | 0% | 27.5 | 42,998 | Common Stock |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 41,500 | 41,500 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2022 | 2,032 | 6,093 | - | - | Restricted Stock Units | |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2022 | 2,032 | 2,032 (0%) | 0% | - | Common Stock | |
| Rhythm Pharma Inc | Yann Mazabraud | EVP, Head of International | Sale of securities on an exchange or to another person at price $ 6.10 per share. | 11 Feb 2022 | 934 | 1,098 (0%) | 0% | 6.1 | 5,697 | Common Stock |